Qt Imaging Holdings (QTI) Liabilities and Shareholders Equity (2021 - 2026)
Qt Imaging Holdings' (QTI) quarterly Liabilities and Shareholders Equity came in at $22.0 million in Q1 2026, up 102.75% year-on-year from $10.9 million in Q1 2025, and down 4.31% on a QoQ basis from $23.0 million in Q4 2025.
Qt Imaging Holdings (QTI) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Qt Imaging Holdings (QTI) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $22.0 million in Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 102.75% year-over-year to $22.0 million in Q1 2026; TTM through Mar 2026 was $68.8 million, a 98.32% increase from a year earlier, with the FY2025 full-year figure at $23.0 million, up 278.2% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $22.0 million, down from $23.0 million in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for QTI reached as high as $233.2 million in Q1 2022 and fell as low as $6.1 million in Q4 2024.
- Historically, Liabilities and Shareholders Equity has averaged $44.8 million across 5 years, with a median of $22.0 million in 2026.
- Across the five-year window, Liabilities and Shareholders Equity slumped 86.15% in 2023 and jumped 278.2% in 2025, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $41.9 million in 2022, then plunged by 84.01% to $6.7 million in 2023, then retreated by 9.24% to $6.1 million in 2024, then soared by 278.2% to $23.0 million in 2025, then declined by 4.31% to $22.0 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $22.0 million in Q1 2026, $23.0 million in Q4 2025, and $12.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Qt Imaging Holdings | 33.72 Mn | 26.82 Mn | 2.67 Mn | 22.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.03 Mn |
| Dec 31, 2025 | 23.02 Mn |
| Sep 30, 2025 | 12.12 Mn |
| Jun 30, 2025 | 11.63 Mn |
| Mar 31, 2025 | 10.86 Mn |
| Dec 31, 2024 | 6.09 Mn |
| Sep 30, 2024 | 6.96 Mn |
| Jun 30, 2024 | 10.78 Mn |
| Mar 31, 2024 | 12.86 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Sep 30, 2023 | 23.14 Mn |
| Jun 30, 2023 | 32.55 Mn |
| Mar 31, 2023 | 32.30 Mn |
| Dec 31, 2022 | 41.95 Mn |
| Sep 30, 2022 | 41.72 Mn |
| Jun 30, 2022 | 233.21 Mn |
| Mar 31, 2022 | 233.23 Mn |
| Dec 31, 2021 | 233.63 Mn |
| Sep 30, 2021 | 235.42 Mn |